deleder2k
Senior Member
- Messages
- 1,130
Has anyone read "Prolonged antibiotic therapy in PCR confirmed persistent Lyme disease" ?
While the study called "Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease" concluded completely different.. http://www.nejm.org/doi/full/10.1056/NEJM200107123450202
How could two trials like this end up with a completely different result? I know they are different in design, but how could the studies end up with two completely different conclusions?
I am also wondering what the sensitivity is for Western Blot and Elisa.
CDC says:
It says that 65% sensitivity is misleading, but how much is it? I've heard 95%, but that information was not from the CDC
Wolfgang Klemann, MD, PhD
Bernt-Dieter Huismans, MD, PhD
Stephan Heyl, MD, PhD
Abstract: We examined a sample of 90 individuals that had previously received a
course of appropriate antibiotics for Lyme disease without experiencing full
resolution of their symptoms and had evidence of persistent infection documented
by PCR analysis.
Mean duration of symptoms was 9.5 years (range 1 - 40 years). The treatment
was adapted to the individual case according to clinical response. Long term
antibiotic therapy was initiated and patients were treated continuously for at
least 6 months, in some cases several years of intermittent therapy was administered.
About 38,8% of the patients experienced full remission of symptoms while about
56,7% reported a significant improvement, 5,6% of patients were deemed
refractory to therapy. Therapeutic modalities are discussed in detail.
Key words: persistent Lyme disease, Borrelia PCR, long term antibiotic
treatment, lyme serology, Borrelia DNA
Key issues:
·
All study patients were Borrelia- DNA positive
·
Commonly reported symptoms included fatigue, muscolo- sceletal and
neuro-psychiatric complaints
·
Only about 42% of patients had a history of an erythema migrans
·
Serologic testing is fairly insensitive in late disseminated lyme disease
·
Antibiotic treatment must be tailored to the individual clinical response in
late disseminated lyme disease
·
The majority of patients benefited from long term antibiotic treatment
·
Recurrence of symptoms was common during treatment
·
Long term antibiotic therapy was generally well tolerated
While the study called "Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease" concluded completely different.. http://www.nejm.org/doi/full/10.1056/NEJM200107123450202
BACKGROUND
It is controversial whether prolonged antibiotic treatment is effective for patients in whom symptoms persist after the recommended antibiotic treatment for acute Lyme disease.
METHODS
We conducted two randomized trials: one in 78 patients who were seropositive for IgG antibodies to Borrelia burgdorferi at the time of enrollment and the other in 51 patients who were seronegative. The patients received either intravenous ceftriaxone, 2 g daily for 30 days, followed by oral doxycycline, 200 mg daily for 60 days, or matching intravenous and oral placebos. Each patient had well-documented, previously treated Lyme disease but had persistent musculoskeletal pain, neurocognitive symptoms, or dysesthesia, often associated with fatigue. The primary outcome measures were improvement on the physical- and mental-health–component summary scales of the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36) — a scale measuring the health-related quality of life — on day 180 of the study.
RESULTS
After a planned interim analysis, the data and safety monitoring board recommended that the studies be discontinued because data from the first 107 patients indicated that it was highly unlikely that a significant difference in treatment efficacy between the groups would be observed with the planned full enrollment of 260 patients. Base-line assessments documented severe impairment in the patients' health-related quality of life. In intention-to-treat analyses, there were no significant differences in the outcomes with prolonged antibiotic treatment as compared with placebo among either the seropositive or the seronegative patients.
CONCLUSIONS
There is considerable impairment of health-related quality of life among patients with persistent symptoms despite previous antibiotic treatment for acute Lyme disease. However, in these two trials, treatment with intravenous and oral antibiotics for 90 days did not improve symptoms more than placebo.
How could two trials like this end up with a completely different result? I know they are different in design, but how could the studies end up with two completely different conclusions?
I am also wondering what the sensitivity is for Western Blot and Elisa.
CDC says:
You may have heard that the blood test for Lyme disease is correctly positive only 65% of the time or less. This is misleading information. As with serologic tests for other infectious diseases, the accuracy of the test depends upon the stage of disease. During the first few weeks of infection, such as when a patient has an erythema migrans rash, the test is expected to be negative.
Several weeks after infection, currently available ELISA, EIA and IFA tests and two-tier testing have very good sensitivity.
It says that 65% sensitivity is misleading, but how much is it? I've heard 95%, but that information was not from the CDC
Last edited: